Stock listing
Biolinerx Ltd.
Selected listing: A41038 · LS · EUR · DE
Biolinerx Ltd. (Lang & Schwarz: A41038), Health Technology. Latest release Sep 10, 2026: BioLineRx and Hemispherian AS to Present Encouraging GLIX1…
- Ticker
- Lang & Schwarz: A41038
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Biolinerx Ltd.
BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
September 10, 2026
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
BioLineRx to Report First Quarter 2026 Results on May 27, 2026
May 20, 2026
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
April 28, 2026
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
April 8, 2026
Events
Research Biolinerx Ltd.
Alternate listings
BLRX:TASE
IL · ILA
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.
BLRX:NASDAQ
US · USD
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.
BLRX:BOATS
US · USD
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.
YP2:FWB
DE · EUR
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.
YP2:GETTEX
DE · EUR
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.
YP2:MUN
DE · EUR
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.
YP2:SWB
DE · EUR
Alternate listing for Biolinerx Ltd.; the primary context on this page is A41038:LS.